AZmed

Founded in 2018, AZmed is a European MedTech company developing AI solutions for medical imaging. Its portfolio includes the Rayvolve® AI Suite for X-rays and the Rayscan® line for CT imaging. Rayvolve® brings together AI tools designed to support diagnostic confidence, improve workflow efficiency, and strengthen operational performance in real-world clinical settings.

AZmed’s solutions are used in more than 2,500 healthcare facilities across 55+ countries. Built for seamless integration into existing radiology workflows, they work within routine reading environments, including PACS/RIS systems, without requiring major changes to clinical practice.

The Rayvolve® AI Suite includes AZtrauma for fracture, dislocation, and joint effusion detection on X-rays, AZchest for chest X-ray analysis, AZmeasure for automated musculoskeletal measurements, and AZboneage for pediatric bone age assessment. In 2025, AZmed expanded beyond X-rays with AZnod, its first CE-marked CT solution within the Rayscan® line for lung nodule detection.

AZmed works side by side with radiologists and healthcare providers to develop clinically validated, workflow-integrated AI that helps imaging teams manage rising demand while maintaining quality, speed, and consistency of care. Rayvolve® includes CE-marked modules and FDA-cleared indications across its product suite.